logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11007141 B1

PDFFull Text
Date of Patent:
May. 18, 2021

Filed:

Dec. 20, 2016

Oral preparation and preparation method thereof

Applicants:

Guangzhou Xiangxue Pharmaceutical Co., Ltd., Guangzhou, CN;

Hangzhou Converd Co., Ltd., Hangzhou, CN;

Inventors:

Shuiping Shi, Hangzhou, CN;

Qingyong Zhang, Hangzhou, CN;

Ronghua Zhao, Hangzhou, CN;

Huihong Chen, Hangzhou, CN;

Lun Zeng, Guangzhou, CN;

Daxin Ou, Guangzhou, CN;

Yan Liu, Guangzhou, CN;

Assignees:

GUANGZHOU XIANGXUE PHARMACEUTICAL CO., LTD., Guangzhou, CN;

HANGZHOU CONVERD CO., LTD., Hangzhou, CN;

Attorney:

Kilpatrick Townsend & Stockton, LLP

Primary Examiner:

James D Anderson

Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/5377 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61P 35/00 (2006.01); A61K 9/19 (2006.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 9/0053 (2013.01); A61K 9/145 (2013.01); A61K 9/19 (2013.01); A61K 9/2018 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 31/5377 (2013.01); A61K 47/6951 (2017.08); A61P 35/00 (2018.01);
Abstract

An oral preparation for treating cell proliferation diseases. The oral preparation comprises hydroxylpropoxyl-β-cyclodextrin and an active component. The active component is KX2-361 or a medicinal salt thereof, and KX2-361 is represented by formula 1. By mixing hydroxylpropoxyl-ydcyclodextrin with KX2-361 or the medicinal salt thereof, an inclusion complex is formed, the solubility of the poorly-soluble drug KX2-361 is greatly improved, and accordingly the drug is prepared into an oral preparation. The oral preparation has good stability, high safety, good absorbability, high bioavailability and economical cost.

Find Patent Forward Citations

Shi, Shuiping. (2021). Oral preparation and preparation method thereof (U.S. Patent No. 11007141). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11007141

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…